BSE filing, NSE: MITSU. Summary written from the filing by ALFA Finder's alert engine.
Mitsu Chem Plast Ltd: key numbers
- Share price
- ₹218.30
- Market cap
- ₹296.4 Cr
- Revenue (annual)
- ₹350.2 Cr
- Net profit (annual)
- ₹15.62 Cr
- P/E (TTM)
- 12.9×Sector 36.4×
- Promoter holding
- 67.77%-0.02% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mitsu Chem Plast Ltd
All →Mitsu Chem Plast Management Change
Mitsu Chem Plast disclosed the resignation of Haresh Sanghvi as its Secretarial Auditor, effective October 26, 2026. No material reason or adverse remark was cited.
Mitsu Chem Plast Convertible Warrants
Mitsu Chem Plast allotted 10 lakh fully convertible warrants at Rs. 151 each, aggregating to Rs. 15.10 Crore. These warrants are convertible into equity shares.
- Value
- ₹15.10 Cr
Mitsu Chem Plast Convertible Warrants
Mitsu Chem Plast Ltd received BSE's in-principle approval to issue 10,00,000 warrants at ₹151 each. This marks a key step in the proposed preferential issue.
- Value
- ₹15.10 Cr
Mitsu Chem Plast Management Change
Ms. Gargi Sawant has resigned as Company Secretary and Compliance Officer of Mitsu Chem Plast Ltd, effective from the close of business hours on September 09, 2026.
Mitsu Chem Plast Annual General Meeting
Mitsu Chem Plast held an EGM on September 09, 2026, to discuss the issuance of 10,00,000 warrants and the appointment of an Independent Director.
Mitsu Chem Plast Capacity Expansion
Mitsu Chem Plast Limited is adding 600 MT/Year to its existing manufacturing capacity. This expansion strengthens its production capabilities to meet demand in industrial packaging and healthcare segments.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.